116818 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Trypsin (3.4.21.4)
3D-PRINTED SKIN MODEL USING PERSONALIZED DECELLULARIZED ECM
#2SEQUENTIAL DIGESTION OF POLYPEPTIDES FOR MASS SPECTROMETRIC ANALYSIS
#3Methods for Assaying a Bodily Sample of a Subject
#4METHOD FOR IN VITRO STORAGE OF ISOLATED MITOCHONDRIA
#5COMPOSITIONS FOR EXPOSING FILM-FORMING MICROBES AND METHODS FOR USE OF THE COMPOSITIONS
#6ENZYME-IMMOBLIZED PARTICLES FOR ONLINE PROTEIN DIGESTION
#7DECELLULARIZED PORCINE SEROSAL BIOMATERIAL AND APPLICATIONS AND USES THEREOF
#8METHOD FOR PREPARING UNDENATURED COLLAGEN TYPE II FOR ALLEVIATING JOINT PAIN
#9Method for Producing Beta-Trypsin
#10MATRIX BOUND NANOVESICLES ENCAPSULATED IN HYDROGELS
#11METHOD FOR ESTABLISHING A MESENCHYMAL STEM CELL SEED BANK BY MIXING TISSUES FROM DIFFERENT DONOR SOURCES
#12PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#13PREPARATION AND APPLICATION OF HIGH-ACTIVITY AND HIGH-SAFETY CARDAMINE VIOLIFOLIA SELENOPROTEIN STANDARD SAMPLE
#14METHODS OF SORTING CELLS FOR PHOTORECEPTOR TRANSPLANTATION TREATMENT
#15CANOLA MEAL EXTRACTS FOR MICROBIAL FERMENTATION
#16EXTRACELLULAR MATRIX FOR THREE-DIMENSIONAL CELL CULTURE AND METHOD FOR PRODUCING SAME
#17METHOD FOR EXTRACTING EPIDERMAL CELLS
#18MATERIALS AND METHODS FOR ISOLATING SELF-ANTIGEN POLYPEPTIDES
#19CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#20CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#21COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#22FACTOR B PROTEASES
#23SOLUBILIZATION OF MSW WITH BLEND ENZYMES
#24ENGINEERED PROTEASES WITH ENHANCED AUTOLYSIS RESISTANCE
#25Process for Preparing a Plant-Based Fermented Dairy Alternative
#26TMPRSS KNOCKOUT SWINE HAVING A REDUCED SUSCEPTIBILITY TO INFLUENZA
#27RNA INTERACTOME CAPTURING PROTOCOL AND ANTIVIRAL COMPOSITION DISCOVERED USING SAME
#28METAL-ORGANIC FRAMEWORK MEDIATED MACROMOLECULE DELIVERY SYSTEM
#29PRETREATMENT METHOD, PRESERVATION METHOD, AUTOMATIC TREATMENT SYSTEM AND DETECTION METHOD FOR URINE SAMPLE
#30Variants of porcine trypsin
#31NOVEL PROINSULIN GLARGINE AND METHOD FOR PREPARING INSULIN GLARGINE THEREFROM
#32COMPOSITIONS FOR EXPOSING FILM-FORMING MICROBES AND METHODS FOR USE OF THE COMPOSITIONS
#33REAGENTS AND METHODS FOR ANTIBODY SEQUENCING
#34PREPARATION OF NON-SOY OILSEED PROTEIN PRODUCTS ("*810")
#35CANCER TREATMENT
#36DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT
#37Non-cellular root canal filler and non-cellular dental tissue regeneration promotion kit
#38Gene for trypsin-like serine protease, a protein encoded thereby and use thereof
#39COMPOSITIONS AND METHODS FOR IDENTIFYING O-LINKED GLYCOSYLATION SITES IN PROTEINS
#40NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS
#41Process for Preparing an Acidified Milk Product
#42PEA PEPTIDE WITH AUXILIARY HYPOGLYCEMIC FUNCTION AND PREPARATION METHOD THEREOF
#43METHOD OF DOUGH RELAXATION INVOLVING ENDOPEPTIDASES
#44TRYPSIN VARIANTS WITH IMPROVED ENZYMATIC PROPERTIES
#45TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS
#46PURIFIED FISH PROTEASES WITH HIGH SPECIFIC ACTIVITIES AND ITS PROCESS OF PRODUCTION
#47Methods for epitope selection
#48Trypsin isoforms and their use
#49COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#50Decellularization of Plant Cell Culture Materials for Tissue Engineering and Drug Delivery
#51HYDROLYSED PHOSPHOLIPID COMPOSITION AND METHOD OF MAKING THE SAME
#52Solubilization of MSW with blend enzymes
#53CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#54Solubilization of MSW with blend enzymes
#55METHOD OF PURIFYING ACTIVE SOLUBLE MATRIX METALLOPROTEINASES
#56Effective disinfectant system for elimination of RNA viruses
#57SEQUENTIAL DIGESTION OF POLYPEPTIDES FOR MASS SPECTROMETRIC ANALYSIS
#58Protein and peptide purification methods
#59Methods and Systems for Measuring Plasma Renin Activity
#60Generation-dependent supramolecular assemblies of protein-dendron conjugates
#61METHODS OF ISOLATING CELLS FROM PLACENTAL TISSUE
#62Antibodies for prevention, treatment and diagnosis of infection
#63CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#64METHODS FOR THE DETECTION OF AUTOLOGOUS BLOOD-DOPING
#65Variants of porcine trypsin
#66COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND FOR THE ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES
#67HYALINE CARTILAGE SHAPING
#68Quantifying MGMT Protein For Optimal Cancer Therapy
#69Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#70DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT
#71Trypsin isoforms and their use
#72Noncrushable pill formulations
#73Decellularization of plant cell culture materials for tissue engineering and drug delivery
#74Agents and methods for treating and preventing seborrheic keratosis
#75HIGHLY MULTIPLEXED AND MASS SPECTROMETRY BASED METHODS TO MEASURING 72 HUMAN PROTEINS
#76CLEAVAGE EVENT TRANSDUCTION METHODS AND PRODUCTS
#77NOVEL TREATMENTS
#78Dental pretreatment material and dental tissue regeneration kit
#79NON-BIOHAZARDOUS SOLUTIONS AND METHODS FOR TESTING ANALYSERS
#80PROENZYME COMPOSITION
#81CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#82Pharmaceutical composition containing a mixture of proenzymes and enzymes
#83PURIFICATION OF ACTIVE SOLUBLE RECOMBINANT MATRIX METALLOPROTEINASE IN ESCHERICHIA COLI
#84Predicting optimal chemotherapy for CRC
#85Methods of preparing antibodies
#86PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#87Supramolecular protein assemblies with advanced functions and synthesis thereof
#88Composition of proenzymes for cancer treatment
#89Technology for the Preparation of Microparticles
#90Cancer treatment
#91Method for preparing broccoli protein peptide mixture
#92Preparation of non-soy oilseed protein products (“*810”)
#93RECOMBINANT SERINE PROTEASES
#94Agents and methods for treating and preventing seborrheic keratosis
#95COMPOSITION FOR RAPIDLY SEPARATING ADIPOSE TISSUE-DERIVED STROMAL CELLS
#96Method for Treating Pervasive Development Disorders
#97Keratin allyl thioether three-dimensional cell culture system
#98Method of diagnosing preeclampsia or pregnancy-induced hypertension
#99METHOD FOR QUANTIFYING MONOCLONAL ANTIBODY
#100METHOD FOR PREPARING BROCCOLI PROTEIN PEPTIDE, BROCCOLI PROTEIN PEPTIDE PREPARED THEREFROM AND USE THEREOF
#101Methods and systems for measuring plasma renin activity
#102Methods for epitope selection
#103METHOD FOR PREPARATION OF A RECOMBINANT PROTEIN FROM A PRECUSOR
#104proNGF mutants and uses thereof for the preparation of NGF mutants
#105Methods and compositions for the treatment of symptoms of prion diseases
#106Assay devices and methods
#107Technology for the Preparation of Microparticles
#108IDENTIFICATION OF THE PRESENCE OF SPECIFIC POLYPEPTIDES BY LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY
#109BMP peptides and methods of use
#110PROTEASE COMPOSITIONS FOR USE IN MODIFYING SEMEN
#111Process for producing recombinant trypsin
#112Solubilization of MSW with blend enzymes
#113IMMUNO-MALDI TO MEASURE AKT1 AND AKT2 PHOSPHORYLATION
#114Chemically stable hollow spherical COF and synthesis thereof
#115Solubilization of MSW with blend enzymes
#116Promoter variants for expressing genes in a fungal cell
#117Hyaline cartilage shaping
#118Hydrophobin mimics: process for preparation thereof
#119AGENTS AND METHODS FOR TREATING AND PREVENTING SEBORRHEIC KERATOSIS
#120METHOD AND ENZYME SOLUTION FOR FLOW-CYTOMETRIC DETECTION OF LIGHT CHAIN RESTRICTION
#121Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#122ORDERED MACROPOROUS HYDROGELS FOR BIORESPONSIVE PROCESSES
#123METHOD FOR TREATING PERVASIVE DEVELOPMENT DISORDERS
#124Deglycosylation reagents and methods
#125NOVEL METHODS, POLYPEPTIDES AND USES THEREOF
#126Technology for the Preparation of Microparticles
#127Reduced-pressure treatment systems and methods employing debridement mechanisms
#128ENZYMATIC DEBRIDEMENT THERAPY FOR ABNORMAL CELL PROLIFERATION
#129METHOD AND COMPOSITION FOR THE TREATMENT OF MODERATE TO SEVERE KERATOCONJUNCTIVITIS SICCA
#130NOVEL TREATMENTS
#131PHARMACEUTICAL COMPOSITION CONTAINING A MIXTURE OF PROENZYMES AND ENZYMES
#132MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME
#133COMPOSITION FOR DISPERSING BIOLOGICAL TISSUE
#134Method of treating proteinuria in pregnancy
#135Mass spectrometric assays for peptides
#136CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#137Human trypsinogen with reduced autoactivation and its use in an immunoassay
#138Technology for the Preparation of Microparticles
#139Methods and compositions for the treatment of symptoms of Williams Syndrome
#140Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging
#141PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#142Mixture to increase the effectiveness of antiseptics and/or disinfectants, an agent containing the mixture, and the use of this mixture
#143Milk-derived basic protein fraction as skin sensitivity improving agent
#144Technology for the Preparation of Microparticles
#145Methods and compositions for the treatment of symptoms of prion diseases
#146Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces
#147Method of treating pregnancy-induced hypertension
#148Prevention, treatment and diagnosis of infection
#149BMP Peptides & Methods of Use
#150Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders
#151METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS
#152Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy
#153Mass spectrometric assays for peptides
#154Method for treating pervasive development disorders
#155Reduced-pressure treatment systems and methods employing debridement mechanisms
#156Reduced-pressure treatment systems and methods employing debridement mechanisms
#157Method for treating pervasive development disorders
#158Promoter variants for expressing genes in a fungal cell
#159Technology for the Preparation of Microparticles
#160Method for treating pervasive development disorders
#161Method for treating pervasive development disorders
#162Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
#163Prevention, treatment and diagnosis of infection
#164Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces
#165Method of Removing Undesired Tissue from Connective Tissue
#166Micro-particles, blood-substitute and method for forming same
#167Reduced-pressure treatment systems and methods employing debridement mechanisms
#168METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#169Methods and compositions for the treatment of symptoms of Williams Syndrome
#170Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy
#171Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders
#172Compositions and use thereof for treating symptoms of preeclampsia
#173Method for identifying autistic individuals amenable to digestive enzyme therapy
#174Method for treating pervasive development disorders
#175Technology for the Preparation of Microparticles
#176Protein hydrolysate compositions having improved sensory characteristics and physical properties
#177Promoter variants for expressing genes in a fungal cell
#178Methods of treating pervasive development disorders
#179Detection and Use of Prolylcarboxypeptidase
#180Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders
#181Enzymatic debridement therapy for abnormal cell proliferation
#182Delayed release pancreatin compositions
#183METHOD OF TREATING AND DIAGNOSING PARKINSONS DISEASE AND RELATED DYSAUTONOMIC DISORDERS
#184One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose
#185Methods for treating pervasive development disorders
#186Methods for treating pervasive development disorders
#187Carboxypeptidases and nucleic acids encoding same
#188Method for extracting unfractionated heparin from camel intestinal mucosa